January 9, 2020 / 8:49 PM / 7 months ago

CORRECTED-BRIEF-Blueprint Medicines Receives FDA Approval For Ayvakit For Treatment Of Rare Stomach Cancer - FDA Website

(Corrects sourcing to 'U.S. FDA' from 'Blueprint Medicines Corp' in text)

Jan 9 (Reuters) - U.S. FDA:

* BLUEPRINT MEDICINES CORP RECEIVES FDA APPROVAL FOR AYVAKIT FOR TREATMENT OF RARE STOMACH CANCER - FDA WEBSITE Source text : (bit.ly/36FFxb1) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below